FDAnews Drug Daily Bulletin

BIOTECH FIRMS TO LAUNCH INJECTABLE ALCOHOLISM TREATMENT

June 14, 2006
A A

A new once-monthly injectable treatment for alcoholism is available starting today, offering patients and physicians another medical option for alcohol addiction. The drug, marketed by Cephalon Inc., in Frazer, Pa., and developed by Alkermes Inc. of Cambridge, Mass., is an extended-release injection form of naltrexone, which has long been available as a daily pill. The Monterey Herald (http://www.montereyherald.com/mld/montereyherald/news/nation/14807615.htm)